Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Hao Q et al. | 2011 | intact cell/cell culture, K562 cells (human erythroleukemic cell line) | static magnetic field | 8.8 mT |
Chen WF et al. | 2010 | intact cell/cell culture, K562 cells (human erythroleukemic cell line) | static magnetic field, co-exposure | 8.8 mT |
Sun RG et al. | 2012 | intact cell/cell culture, K562 cells (human erythroleukemic cell line) | static magnetic field | 8.8 mT |
Iwamoto KS et al. | 2021 | intact cell/cell culture, Lewis lung carcinoma (LLC) cells, human glioblastoma cells (U87MG-viii), animal | static magnetic field, co-exposure | - |
Nieminen V et al. | 2022 | intact cell/cell culture, MCF-7 (human breast cancer cell line) | static magnetic field, magnetic field, 50/60 Hz, co-exposure, also other exposures without EMF | - |
Romeo S et al. | 2016 | intact cell/cell culture, MRC-5 (human primary fetal lung fibroblasts) | static magnetic field | 370 mT |
Amara S et al. | 2007 | intact cell/cell culture, THP-1 cells (human monocytic leukemia cell line) | static magnetic field | 250 mT |
Halicka HD et al. | 2009 | intact cell/cell culture, TK6 cells (lymphoblastoma cells) | static magnetic field | 705 mT |
Ngo FQ et al. | 1987 | intact cell/cell culture, V79 (Chinese hamster fibroblast cells) | static magnetic field, co-exposure | 750 mT |
Li Y et al. | 2014 | intact cell/cell culture, culture medium, K562 and HEL 92.1.7 cells (human erythroleukemic cell lines), MCF-7 cells (human breast cancer cell line), NCI-H460 cells (human lung cancer cell line), Colo 320 DM cells (human colon carcinoma cell line) | magnetic field, static magnetic field, 50/60 Hz, shielding/field deprivation | 4 nT–74 µT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.